We are live on ! Find out more
KYMR icon

Kymera Therapeutics
KYMR

97 hedge funds and large institutions have $887M invested in Kymera Therapeutics in 2021 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 28 increasing their positions, 25 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

367% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 6

29% more funds holding

Funds holding: 75 → 97 (+22)

12% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 25

5.29% more ownership

Funds ownership: 45.66% → 50.95% (+5.3%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

29% less capital invested

Capital invested by funds: $1.25B → $887M (-$360M)

Holders
97
Holders Change
+22
Holders Change %
+29.33%
% of All Funds
1.7%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
28
Increased
28
Reduced
25
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$66.8M
2
State Street
State Street
Massachusetts
+$46.7M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$32.6M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$23.9M
5
Morgan Stanley
Morgan Stanley
New York
+$20.1M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$61.5M
2
CCM
CAAS Capital Management
New York
-$10.5M
3
WP
Woodline Partners
California
-$10.5M
4
TOCUITCONY
Trustees of Columbia University in the City of New York
New York
-$9.04M
5
RG
Redmile Group
California
-$7.06M
Name Holding Trade Value Shares
Change 		Change in
Stake
Adage Capital Partners
26
Adage Capital Partners
Massachusetts
$3.89M – – –
EC
27
EcoR1 Capital
California
$3.89M – – –
Voloridge Investment Management
28
Voloridge Investment Management
Florida
$3.86M +$5.98M +99,365 New
Balyasny Asset Management
29
Balyasny Asset Management
Illinois
$2.5M +$3.87M +64,310 New
Citigroup
30
Citigroup
New York
$2.48M +$3.71M +61,653 +3,034%
Ensign Peak Advisors
31
Ensign Peak Advisors
Utah
$2.44M +$2.57M +42,740 +214%
Charles Schwab
32
Charles Schwab
California
$2.43M +$67.1K +1,114 +2%
JP Morgan Chase
33
JP Morgan Chase
New York
$2.29M +$2.21M +36,771 +166%
Rafferty Asset Management
34
Rafferty Asset Management
New York
$2.01M +$3.12M +51,810 New
Jane Street
35
Jane Street
New York
$1.57M +$2.22M +36,931 +1,066%
N
36
Nuveen
North Carolina
$1.53M +$39.8K +661 +2%
Susquehanna International Group
37
Susquehanna International Group
Pennsylvania
$1.49M +$2.31M +38,429 New
Bank of New York Mellon
38
Bank of New York Mellon
New York
$1.49M -$116K -1,924 -5%
Bank of America
39
Bank of America
North Carolina
$1.26M +$1.72M +28,551 +751%
PMAM
40
Penn Mutual Asset Management
Pennsylvania
$1.18M +$1.83M +30,327 New
SCM
41
Soleus Capital Management
Connecticut
$1.09M +$903K +15,000 +114%
TD Asset Management
42
TD Asset Management
Ontario, Canada
$1.03M +$217K +3,598 +16%
UBS Group
43
UBS Group
Switzerland
$989K +$1.31M +21,829 +604%
Swiss National Bank
44
Swiss National Bank
Switzerland
$979K – – –
CSS
45
Cubist Systematic Strategies
Connecticut
$968K +$1.5M +24,917 New
Russell Investments Group
46
Russell Investments Group
United Kingdom
$951K +$1.19M +19,705 +396%
Norges Bank
47
Norges Bank
Norway
$856K +$423K +7,030 +47%
JF
48
Jump Financial
Illinois
$701K +$1.09M +18,037 New
California Public Employees Retirement System
49
California Public Employees Retirement System
California
$692K -$98.5K -1,637 -8%
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
$591K -$2.77K -46 -0.3%
1
2
3 4 5

KYMR Hedge Fund Activity: Q1 2021 in Review

97 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Kymera Therapeutics (KYMR) for Q1 2021, worth a combined $887M — down 29% from $1.25B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new KYMR positions and 6 closed out — a net gain of 22 holders — while 28 added to existing stakes and 25 trimmed.

The largest buyer was Vanguard Group, adding an estimated $66.8M. The largest seller was Wellington Management Group, cutting an estimated $61.5M.

  • 97 institutional investors held Kymera Therapeutics (KYMR) as of Q1 2021, up from 75 in Q4 2020.
  • Funds reported $887M of Kymera Therapeutics stock for Q1 2021, down 29% quarter-over-quarter.
  • 28 funds opened new Kymera Therapeutics positions in Q1 2021 and 6 closed out, a net change of +22 holders.
  • The largest Kymera Therapeutics buyer in Q1 2021 was Vanguard Group, an estimated $66.8M added.
  • The largest Kymera Therapeutics seller in Q1 2021 was Wellington Management Group, an estimated $61.5M sold.

Based on aggregated 13F filings for Q1 2021.